Search Results

You are looking at 41 - 50 of 65 items for

  • Author: S. Harvey x
  • Refine by access: All content x
Clear All Modify Search
T. R. Hall
Search for other papers by T. R. Hall in
Google Scholar
PubMed
Close
,
A. Cheung
Search for other papers by A. Cheung in
Google Scholar
PubMed
Close
, and
S. Harvey
Search for other papers by S. Harvey in
Google Scholar
PubMed
Close

ABSTRACT

Immature cockerels were injected with drugs known to affect serotoninergic activity. The receptor agonist quipazine as well as pargyline, an inhibitor of serotonin breakdown, both reduced plasma LH concentrations in a time-dependent fashion. The effect of pargyline was also dose-related. The serotonin precursor, tryptophan, reduced plasma LH levels. Tryptophan and pargyline were as effective in pubertal cockerels as in 3-week-old birds. Responses to quipazine were attenuated by the antagonist, methysergide, although another antagonist, cyproheptadine, also reduced plasma LH levels. Serotonin itself had no effect on plasma LH levels. Parachlorophenylalanine, which blocks serotonin synthesis, had no effect on plasma LH by itself, but attenuated the tryptophan-induced inhibition of LH. These data indicate that serotoninergic mechanisms inhibit secretion of LH in domestic fowl. This mechanism probably operates through the central nervous system.

J. Endocr. (1986) 110, 239–244

Restricted access
C. Foltzer-Jourdainne
Search for other papers by C. Foltzer-Jourdainne in
Google Scholar
PubMed
Close
,
S. Harvey
Search for other papers by S. Harvey in
Google Scholar
PubMed
Close
, and
P. Mialhe
Search for other papers by P. Mialhe in
Google Scholar
PubMed
Close

ABSTRACT

Release of GH from perifused duckling hemipituitaries was stimulated, in a biphasic manner, by synthetic TRH and human pancreatic GH-releasing factor (GRF). At all effective concentrations, the level of GH release was increased within 5 min of TRH or GRF perifusion and was maximal after 10 min of TRH perifusion and after 20 min of GRF perifusion. Although TRH was perifused for 20 min the level of GH release declined during the last 10 min. The most effective dose of TRH (1·0 μg/ml; 2·7 μmol/l) and GRF (0·5 μg/ml; 110 nmol/l) provoked similar (250– 300%) increases in the level of GH release. However, since the effect of TRH was only of short duration, the total release of GH induced by GRF was higher than that elicited by TRH, especially with the low dose. The increase in release of GH induced by TRH or GRF was blunted when pituitaries from adult ducks were used. As in young ducks, the GH response to GRF was higher, whereas the response to TRH was very low. The GH response of perifused adult pituitaries to GRF was, however, potentiated when TRH was perifused simultaneously. The basal release of GH from both young and adult pituitary glands was unaffected by perifusion with somatostatin-14 (SRIF-14) at doses of 1 and 2 μg/ml. The perifusion of hemipituitary glands with similar doses of SRIF-14 was also unable to suppress the stimulation of GH release induced by prior perifusion with GRF, although when SRIF-14 and TRH were simultaneously perifused TRH-induced GH release was markedly suppressed.

These results demonstrate direct effects and interactions of TRH, GRF and SRIF on the release of GH from duck pituitary glands. GRF is the most potent releasing factor for GH in both young and adult ducks although in adult ducks it is less effective. These results also provide evidence that the age-related decline in the in-vivo GH response to TRH is due to a desensitization of pituitary somatotrophs.

J. Endocr. (1988) 119, 421–429

Restricted access
AE Murphy
Search for other papers by AE Murphy in
Google Scholar
PubMed
Close
,
H Peek
Search for other papers by H Peek in
Google Scholar
PubMed
Close
,
ML Baudet
Search for other papers by ML Baudet in
Google Scholar
PubMed
Close
, and
S Harvey
Search for other papers by S Harvey in
Google Scholar
PubMed
Close

GH has previously been shown to be present in peripheral extrapituitary tIssues of chick embryos, but the cellular distribution of GH immunoreactivity is still uncertain because of differing immunohistochemical findings. The possibility that this uncertainty reflects differences in fixation of the embryonic tIssues was assessed by comparing GH immunoreactivity in tIssues fixed in 4% (w/v) paraformaldehyde or Carnoy's fluid (60% ethanol (v/v); 30% chloroform (v/v); 10% acetic acid (v/v)). A widespread distribution of GH immunoreactivity was seen in paraformaldehyde-fixed tIssues, although it was particularly intense in the spinal cord, dorsal and ventral root ganglia, notochord, myotome, epidermis, crop, heart, lung and humerus. In marked contrast, GH immunoreactivity in embryonic tIssues fixed with Carnoy's was more discrete and mainly restricted to marginal and mantle layers of the spinal cord, spinal nerves, the ventral root ganglia and the extensor nerve of the anterior limb bud. Since these are neural derivatives, Carnoy's fixation appears to preferentially result in neural GH staining, whereas GH staining in neural and non-neural tIssues is seen after paraformaldehyde fixation. Carnoy's, because it is a precipitive fixative, may only fix large GH moieties, whereas GH in peripheral tIssues includes numerous molecular variants, many of which are of relatively small size. Paraformaldehyde, because it is a cross-linking fixative, preferentially fixes peptides and small proteins, and it may therefore fix more GH moieties than Carnoy's fluid. Carnoy's fixation appears to underestimate GH immunoreactivity in immunohistochemical studies on the cellular distribution of GH-like proteins in embryonic chicks.

Free access
S. Harvey
Search for other papers by S. Harvey in
Google Scholar
PubMed
Close
,
S.-K. Lam
Search for other papers by S.-K. Lam in
Google Scholar
PubMed
Close
, and
T. R. Hall
Search for other papers by T. R. Hall in
Google Scholar
PubMed
Close

ABSTRACT

Passive immunization of immature chickens with sheep somatostatin (SRIF) antiserum promptly increased the basal plasma GH concentration and augmented TRH-induced GH secretion. Although exogenous SRIF had no inhibitory effect on the basal GH concentration in untreated birds or birds pretreated with non-immune sheep serum, it suppressed the stimulatory effect of SRIF immunoneutralization on GH secretion. These results suggest that SRIF is physiologically involved in the control of GH secretion in birds, in which it appears to inhibit GH release tonically.

J. Endocr. (1986) 111, 91–97

Restricted access
A. Cheung
Search for other papers by A. Cheung in
Google Scholar
PubMed
Close
,
S. Harvey
Search for other papers by S. Harvey in
Google Scholar
PubMed
Close
,
T. R. Hall
Search for other papers by T. R. Hall in
Google Scholar
PubMed
Close
,
S.-K. Lam
Search for other papers by S.-K. Lam in
Google Scholar
PubMed
Close
, and
G. S. G. Spencer
Search for other papers by G. S. G. Spencer in
Google Scholar
PubMed
Close

ABSTRACT

Young cockerels (6–8 weeks old) were injected with serum from sheep immunized against somatostatin-14 (anti-SRIF) or normal sheep serum (NSS). Blood samples were withdrawn periodically for the determination of plasma corticosterone concentration by radioimmunoassay. With frequent (every 10 min) sampling, NSS-treated control animals exhibited increased plasma corticosterone levels, presumably as a stress response to the experimental manipulation. Anti-SRIF stimulated a much greater increase in plasma corticosterone concentrations and a peak response was observed within 10 to 20 min, when the plasma corticosterone level reached more than twice that of the corresponding control value. With less frequent sampling, plasma corticosterone increased with anti-SRIF administration to as much as nine times the corresponding control value, and the peak response occurred much later. Under pentobarbitone anaesthesia, which itself increased basal corticosterone concentrations, anti-SRIF treatment promoted further increases in plasma corticosterone levels although to a smaller magnitude compared with conscious birds. The results suggest that endogenous somatostatin may play a role in the regulation of adrenocortical function in the domestic fowl. The mechanism of response may involve a central component.

J. Endocr. (1988) 116, 179–183

Restricted access
S.-K. Lam
Search for other papers by S.-K. Lam in
Google Scholar
PubMed
Close
,
S. Harvey
Search for other papers by S. Harvey in
Google Scholar
PubMed
Close
,
T. R. Hall
Search for other papers by T. R. Hall in
Google Scholar
PubMed
Close
, and
G. S. G. Spencer
Search for other papers by G. S. G. Spencer in
Google Scholar
PubMed
Close

ABSTRACT

The influence of somatostatin on thyroid function has been examined in immature domestic fowl passively immunized with somatostatin antiserum. Plasma thyroxine (T4) and tri-iodothyronine (T3) concentrations were markedly increased within 10 min of antisomatostatin administration and remained raised for at least 5 h. The increases in the T3 and T4 concentrations following somatostatin immunoneutralization were directly related to the volume of antisera administered. The increase in the T3 concentration exceeded the increase in the T4 concentration, resulting in a T3: T4 ratio greater than unity. While the raised T4 concentration began to decline 30 min after antisomatostatin administration, raised T3 concentrations were sustained for at least 2 h, and further increased the plasma T3: T4 ratio.

These results demonstrate that somatostatin immunoneutralization stimulates thyroid function in fowl. The magnitude and rapidity of the thyroidal responses to somatostatin immunoneutralization suggests that they occur independently of the hypothalamic-pituitary-thyroid axis. Somatostatin appears to exert a tonic inhibitory control on avian thyroid function, possibly by effects mediated at the thyroid gland to inhibit T4 release and by peripheral effects to suppress the conversion of T4 and T3.

J. Endocr. (1986) 110, 127–132

Restricted access
C. A. Ahene
Search for other papers by C. A. Ahene in
Google Scholar
PubMed
Close
,
R. W. Lea
Search for other papers by R. W. Lea in
Google Scholar
PubMed
Close
, and
S. Harvey
Search for other papers by S. Harvey in
Google Scholar
PubMed
Close

ABSTRACT

Intracerebroventricular (i.c.v.) administration of GH-releasing factor (GRF) (at 1 or 10 μg) to anaesthetized immature (6- to 8-weeks-old) or adult (> 24-weeks-old) domestic fowl had no effect on basal GH concentrations in peripheral plasma, but suppressed (after 20 min) the acute GH response to exogenous (i.v.) thyrotrophin-releasing hormone (TRH) (1 μg/kg). The i.c.v. injection of GRF also reduced the content of somatostatin (SRIF) and dopamine (DA) in the hypothalamus, while increasing the concentration of the DA metabolite 3,4-dihydroxyphenyl acetic acid (DOPAC) and the DOPAC/DA ratio. The release of SRIF from hypothalamic tissue was stimulated in vitro by 100 nmol GRF/l. The inhibitory effect of i.c.v. GRF on TRH-induced GH secretion was blocked when it was simultaneously injected i.c.v. with SRIF antiserum.

These results demonstrate central effects of GRF on avian hypothalamic function and suggest an inhibitory role for this peptide in GH regulation, possibly mediated through increased SRIF secretion.

Journal of Endocrinology (1991) 128, 13–19

Restricted access
Ch. Foltzer-Jourdainne
Search for other papers by Ch. Foltzer-Jourdainne in
Google Scholar
PubMed
Close
,
S. Harvey
Search for other papers by S. Harvey in
Google Scholar
PubMed
Close
,
H. Karmann
Search for other papers by H. Karmann in
Google Scholar
PubMed
Close
, and
P. Mialhe
Search for other papers by P. Mialhe in
Google Scholar
PubMed
Close

ABSTRACT

Human pancreatic GH-releasing factor (hpGRF) increased the concentrations of plasma GH when infused i.v. into immature ducks. A dose-dependent increase in plasma GH was observed within 10 min of the start of infusion and was maintained during the 30-min infusion period. Simultaneous infusion of somatostatin S-14 prevented the increase in plasma GH induced by hpGRF, but when the infusion had finished there was a rebound increase in plasma GH. Infusion of the highest dose of hpGRF (800 ng/kg per min) in adult ducks had no significant effect on plasma GH.

Plasma somatostatin concentrations were reduced during the infusion of hpGRF in young but not in adult ducks. This observation suggests that the stimulatory effect of hpGRF on GH secretion may be partly due to its inhibitory effect on somatostatin secretion. Infusion of hpGRF in ducklings also increased the concentrations of glucagon and decreased levels of insulin in the plasma. Peripheral plasma glucagon and insulin levels in adult ducks were unaffected by hpGRF infusion. These results indicate that in ducklings, hpGRF increases plasma GH and glucagon concentrations and lowers plasma somatostatin and insulin levels. In the adult, these hormonal responses to hpGRF are not maintained. The highly stimulatory effect of hpGRF on GH secretion in ducklings may explain why plasma GH concentrations are high in these birds.

J. Endocr. (1987) 114, 25–32

Restricted access
Ch. Foltzer
Search for other papers by Ch. Foltzer in
Google Scholar
PubMed
Close
,
M. Th. Strosser
Search for other papers by M. Th. Strosser in
Google Scholar
PubMed
Close
,
S. Harvey
Search for other papers by S. Harvey in
Google Scholar
PubMed
Close
, and
P. Mialhe
Search for other papers by P. Mialhe in
Google Scholar
PubMed
Close

ABSTRACT

The effects of plasma free fatty acids (FFA) and somatostatin-14 (S-14) on concentrations of plasma GH, glucagon and insulin were investigated in juvenile ducks. Oleic acid, S-14 or both were infused into 4- to 7-week-old birds and plasma GH, glucagon-like immunoreactivity (GLI), immunoreactive insulin (IRI) and FFA were measured.

An increase in plasma GH and a decrease in GLI but no change in IRI was observed after infusion of 9 mg oleic acid/kg per min. A decrease in plasma GH, FFA and IRI and an increase in plasma GLI was seen after infusion of 800 ng S–14/kg per min. These effects of S-14 on IRI and GLI were abolished when S-14 was infused simultaneously with oleic acid.

It is concluded that FFA have a direct stimulatory effect on GH secretion and an inhibitory effect on glucagon secretion. Somatostatin-14 directly inhibits the secretion of GH and its stimulatory effect on the secretion of glucagon is mediated by a depression in concentrations of plasma FFA. Finally, S-14 has no effect on plasma insulin when basal levels of plasma FFA are maintained.

J. Endocr. (1985) 106, 21–25

Restricted access
C. G. Scanes
Search for other papers by C. G. Scanes in
Google Scholar
PubMed
Close
,
S. Harvey
Search for other papers by S. Harvey in
Google Scholar
PubMed
Close
,
J. Rivier
Search for other papers by J. Rivier in
Google Scholar
PubMed
Close
, and
W. Vale
Search for other papers by W. Vale in
Google Scholar
PubMed
Close

ABSTRACT

Rat hypothalamic GH-releasing factor (rhGRF), at doses between 0·1 and 10 μg/kg, increased plasma GH concentrations in immature domestic fowl 5–10 min after i.v. injection. Sodium pentobarbitone anaesthesia blunted the GH responses to rhGRF, although in both conscious and anaesthetized chicks the maximal responses were induced by a dose of 1 μg rhGRF/kg. The stimulatory effect of rhGRF on in-vivo GH secretion was less than that provoked by corresponding doses of human pancreatic GRF, but greater than that elicited by two rhGRF analogues, (Nle27)-rhGRF(1–32) and (Nle27)-rhGRF(1–29). These results demonstrate that the chicken pituitary is responsive to mammalian GRF and provide evidence of structure-activity relationships of GRF in the domestic fowl.

J. Endocr. (1986) 108, 413–416

Restricted access